消息面上,健倍苗苗公布,2月21日,该公司间接全资附属Arrow King Inc.拟向侯佳声收购天喜堂药厂有限公司已发行股份的90%,总代价为1.71亿港元。据悉目标公司主要从事制造、推广及销售品牌中药天喜堂天喜丸。集团认为,天喜堂天喜丸是一个极具价值的优质品牌,为集团的长远业务增长带来重要的战略价值。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.